Cargando…
A Single Dose of ChAdOx1 nCoV-19 Vaccine Elicits High Antibody Responses in Individuals with Prior SARS-CoV-2 Infection Comparable to That of Two-Dose-Vaccinated, SARS-CoV-2-Infection-Naïve Individuals: A Longitudinal Study in Ethiopian Health Workers
Single-dose COVID-19 vaccines, mostly mRNA-based vaccines, are shown to induce robust antibody responses in individuals who were previously infected with SARS-CoV-2, suggesting the sufficiency of a single dose for those individuals in countries with limited vaccine supply. However, these important d...
Autores principales: | Gelanew, Tesfaye, Mulu, Andargachew, Abebe, Markos, Bates, Timothy A., Wassie, Liya, Teferi, Mekonnen, Fentahun, Dessalegn, Alemu, Aynalem, Tamiru, Frehiwot, Assefa, Gebeyehu, Bayih, Abebe Genetu, Tafesse, Fikadu G., Mihret, Adane, Abdissa, Alemseged |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9229151/ https://www.ncbi.nlm.nih.gov/pubmed/35746467 http://dx.doi.org/10.3390/vaccines10060859 |
Ejemplares similares
-
A single dose ChAdOx1 nCoV-19 vaccine elicits high antibody responses in individuals with prior SARS-CoV-2 infection comparable to that of double dose vaccinated SARS-CoV-2 infection naïve individuals
por: Gelanew, Tesfaye, et al.
Publicado: (2022) -
Whole-Genome Sequences of SARS-CoV-2 Isolates from Ethiopian Patients
por: Alemayehu, Dawit Hailu, et al.
Publicado: (2021) -
Evaluation of sample pooling for screening of SARS CoV-2
por: Mulu, Andargachew, et al.
Publicado: (2021) -
High Seroprevalence of Anti-SARS-CoV-2 Antibodies Among Ethiopian Healthcare Workers
por: Gelanew, Tesfaye, et al.
Publicado: (2021) -
High seroprevalence of anti-SARS-CoV-2 antibodies among Ethiopian healthcare workers
por: Gelanew, Tesfaye, et al.
Publicado: (2022)